How can you deal with a virus that has the capability of even switching its entry route?

Laboratory experiments demonstrate that #Omicron has switched its route of entry in to human cells. 1/
This is likely to influence #Omicron spread and the types of cells it can hijack. 2/
#SARS2 can enter cells via two routes, both routes require spike activation by proteases.

Route 1: Cell surface fusion, triggered by #TMPRRS2.

Route 2: endosomal fusion, triggered by cathepsins.

So far SARS2 has favoured Route 1.
3/
There is strong evidence of a dramatic switch in #Omicron entry route from cell surface to endosomal fusion. 4/
Omicron has shifted from a TMPRSS-2-dependent fusion at the cell surface, to a cathepsin-dependent endosomal fusion. So, the preferred entry mechanism of Omicron is different now (ie, it's a big big big change). 5/
Another consequence of this switch is that #Omicron can no longer mediate TMPRSS2-dependent fusion of infected cells with adjacent non-infected cells. So reduced fusogenicity may not hamper its infectivity! 6/
Omicron may be deficient at syncytium formation but it can move to other cells better than previous thru enhanced endosome fusion.

This sort of thing could affect tissue tropism, the tendency of a particular variant to invade a particular organ or not. 7/
These discoveries may have implications for the tissue preference of #Omicron and for viral transmission. 8/

These results were confirmed by other researchers too with the freshest results by @PeacockFlu and team. 9/
@PeacockFlu proposes a model where Omicron has become less specialised in its entry route and become more of a 'generalist' - this allows it to efficiently infect a greater number of cells in the upper respiratory tract and may mean it even has a lower infectious dose? 10/
@PeacockFlu also concludes that Omicron Spike is more able to use the endosomal entry route than previous variants, being less sensitive to TMPRSS2-mediated entry and more sensitive to inhibitors of endosomal entry. 11/

We all know about the ‘furin cleavage site’ (FCS) at S1/S2 junction. Similar to this FCS, the 637 cathepsin site is located in a flexible loop region, which would allow cleavage. 12/

It will be important to tease out what the drop in TMPRSS-2 cleavage & the increase of importance for cathepsin-dependent entry causes in #Omicron. If it is due to epistatic effects by several mutations the reversion is likely a multi-step process. 13/
And if this could change back to a TMPRSS-2 use and likely associated pathogenicity in a much easier way?? this is purely speculative at this point.

14/
The new findings on Omicron’s preferred way of entry to the host cell led to new sketches 👇

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Vipin M. Vashishtha

Vipin M. Vashishtha Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @vipintukur

13 Nov 21
What happens if we allow #SARS2 to become endemic? What’s going to happen to us & what’s going to happen to the virus?

If we allow it to become endemic—and some would argue that it is already endemic—this does not mean that it is going to attenuate, not whatsoever. 1/
It is not true that more transmissible versions of #SARS2 will be more benign. What we are seeing is more aggressive, more transmissible versions which are creating more severe illness. And the virus is still adapting to our physiology. It’s doing it at a fantastic rate 2/
What we’re going to see is that it will continue to work against our immune systems, meaning become more immune evasive. It’s going to become more chronic as an infection. 3/
Read 14 tweets
12 Nov 21
Natural immunity post-#SARS2 infection may not be perfect agains #Delta variant!!

A new study from #Australia:

“The duration & magnitude of #SARS2 immunity after infection, especially wrt the emergence of new VOCs”

1/
At 12 months after mild-COVID19:

1->90% of convalescents remained seropositive for RBD-IgG & 88.9% had circulating RBD-specific memory B cells.

2-Despite this, only 51.2% convalescents had serum neutralising activity against homologous live-SARS2 virus

2/
3-The neutralising activity decreased to 44.2% against live Alpha, 4.6% against Beta, 11.6% against Gamma & 16.2%, against Delta

4-Spike & non-Spike-specific T cells were detected in >50% of convalescents

3/
Read 7 tweets
15 Oct 21
Iranian #COVID19 epidemic: Salient features

Continued circulation of #SARS2 from late jan 2020 to Sep 2021 in iran despite >100% attack rates in 11 provinces. 1/ Image
As of Sep 21, only 48% (95% CI: 43-55%) of COVID deaths in Iran have been reported. Approx 0.4% of the population have died of COVID so far
Estimated #IFR increased by a factor of ~2 over the course of the epidemic (from wave 1 to 5).

Across different ages, the 3rd wave in Oct 2020 & the current wave with #Delta had the largest impact on younger age-groups. 3/
Read 5 tweets
14 Oct 21
Are the #boosters already waning?

Booster effectiveness against breakthrough coronavirus infection is already waning.

The protection against infection among Pfizer booster recipients ages 60+ topped out by day 30 then fell steadily. 1/ Image
By day 58, the #booster appeared to be providing around 40% of the maximum increased level of protection above the initial 2-dose series.

New data finds boosters are helping more than just 50+, but that the effects already appear to be decreasing. 2/ Image
Bottom line: The case for boosters to prevent infection for all adults is now far stronger, if that is our goal. But how long that protection lasts remains unclear at best and boosters may turn out to lower the #Ro of #SARS2 only briefly. 3/
Read 5 tweets
3 Oct 21
How effective are #COVID vaccines against #transmissions?

Key points:

1-Vaccination reduces transmission of #Delta, but by less than #Alpha
2-Alpha: Pfizer 62%, AZ 38% reduction
Delta: Pfizer 37%, AZ 15% reduction (aOR)
3-The impact of vaccination decreased over time 1/
4-Vaccinated people with breakthrough infections were less likely to spread Covid.
5-Vaccination not only reduces the risk of becoming seriously ill from the virus, it also protects those around you. 2/
6-Contacts of vaccinated cases were less likely get Covid than contacts of unvaccinated cases.
7-Most transmission occurred in households, showing that vaccination can protect household members—including kids not yet eligible for vaccination. 3/

medrxiv.org/content/10.110…
Read 4 tweets
2 Oct 21
No doubt, #molnupiravir is touted as a ‘game changer’ as far as therapeutics against #SARS2 are concerned. But the news related to its probable #mutagenic potential comes as a dampener 1/
#rNHC, an active metabolite of #Molnupiravir, inhibits SARS2 replication in cell cultures through lethal mutagenesis, but is also mutagenic to mammalian host cells 2/

Read this paper👇
academic.oup.com/jid/article/22…
#rNHC has powerful in vitro and in vivo activity against a large number of highly pathogenic emerging RNA viruses and represents a potentially important drug for use in the current and future pandemics. 3/
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(